BioNexus Gene Lab (BGLC) Competitors $0.25 -0.05 (-16.41%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$0.25 0.00 (-0.84%) As of 03/28/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. CCM, MRAI, BRTX, KDLY, MGRX, SSY, OTRK, NIVF, ATIP, and DHACShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Concord Medical Services (CCM), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), NewGenIvf Group (NIVF), ATI Physical Therapy (ATIP), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Concord Medical Services Marpai BioRestorative Therapies Kindly MD Mangoceuticals SunLink Health Systems Ontrak NewGenIvf Group ATI Physical Therapy Digital Health Acquisition Concord Medical Services (NYSE:CCM) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation and community ranking. Is CCM or BGLC more profitable? Concord Medical Services has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -10.17%. Concord Medical Services' return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioNexus Gene Lab -10.17%-9.93%-8.43% Does the MarketBeat Community believe in CCM or BGLC? Concord Medical Services received 197 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19759.52% Underperform Votes13440.48% BioNexus Gene LabN/AN/A Which has higher valuation & earnings, CCM or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$471.70M0.04-$41.93MN/AN/ABioNexus Gene Lab$9.26M0.49-$2.63MN/AN/A Do insiders & institutionals hold more shares of CCM or BGLC? 18.9% of BioNexus Gene Lab shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 0.7% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer CCM or BGLC? In the previous week, Concord Medical Services and Concord Medical Services both had 2 articles in the media. BioNexus Gene Lab's average media sentiment score of 1.44 beat Concord Medical Services' score of -0.50 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Negative BioNexus Gene Lab Positive Which has more risk & volatility, CCM or BGLC? Concord Medical Services has a beta of -0.49, meaning that its stock price is 149% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 5.79, meaning that its stock price is 479% more volatile than the S&P 500. SummaryConcord Medical Services beats BioNexus Gene Lab on 6 of the 11 factors compared between the two stocks. Remove Ads Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.49M$2.83B$5.63B$7.83BDividend YieldN/A22.57%4.57%4.01%P/E RatioN/A13.1723.3318.67Price / Sales0.49202.00388.4691.01Price / CashN/A57.5638.1634.64Price / Book0.454.356.894.23Net Income-$2.63M-$22.21M$3.20B$247.15M7 Day Performance-12.25%51.05%-2.98%-2.17%1 Month Performance-23.63%12.95%1.63%-5.68%1 Year Performance-64.58%-3.70%9.44%-0.74% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab1.1472 of 5 stars$0.25-16.4%N/A-64.6%$4.49M$9.26M0.0030Short Interest ↓CCMConcord Medical Services0.5331 of 5 stars$3.96+3.4%N/A-23.8%$17.19M$471.70M0.00970Short Interest ↑MRAIMarpaiN/A$1.15+21.1%$6.00+421.7%-59.0%$16.65M$34.87M-0.44150News CoverageGap UpBRTXBioRestorative Therapies3.4969 of 5 stars$1.97+11.9%$18.00+813.7%+31.2%$13.63M$377,000.00-1.297Short Interest ↓News CoverageGap UpKDLYKindly MDN/A$2.18+44.4%N/AN/A$13.03M$2.88M0.00N/AEarnings ReportPositive NewsGap DownHigh Trading VolumeMGRXMangoceuticals0.6146 of 5 stars$4.75+6.5%N/A-95.1%$11.81M$755,000.00-0.823SSYSunLink Health SystemsN/A$1.05-2.8%N/A+36.9%$7.60M$31.23M7.501,376Analyst ForecastNews CoverageOTRKOntrak2.9768 of 5 stars$1.70+9.7%$45.00+2,547.1%-80.5%$7.17M$11.24M-0.16250Gap UpNIVFNewGenIvf Group1.1544 of 5 stars$1.08+10.2%N/AN/A$5.69M$5.14M0.00N/AGap UpATIPATI Physical TherapyN/A$1.23+1.7%N/A-78.7%$5.43M$741.86M-0.075,600DHACDigital Health AcquisitionN/A$1.21-1.6%N/A-89.0%$4.36MN/A0.002,021 Remove Ads Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives BRTX Alternatives KDLY Alternatives MGRX Alternatives SSY Alternatives OTRK Alternatives NIVF Alternatives ATIP Alternatives DHAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGLC Stock Free BGLC Stock Alerts